Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Date
On January 1, 2021 significant changes will be coming to the office and outpatient Evaluation and Management services. Begin the process of preparing your practice with these three steps:
Start getting your practice ready for the changes to the Evaluation and Management (E&M) codes in 2021 by reading ASCO’s new resource Nine Essential Tips to Prepare Your Practice for the 2021 Evaluation and Management Coding Changes.
Due to the Public Health Emergency (PHE), the Centers for Medicare and Medicaid Services (CMS) is suspending most Medicare Fee-For-Services (FFS) medical reviews. This includes pre-payment reviews conducted by Medicare Administrative Contractors (MACs) under the Targeted Probe and Educate (TPE) program and post-payment reviews conducted by the MACs, Supplemental Medical Review Contractor (SMRC) reviews and Recovery Audit Contractors (RACs).
Starting January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT ®) codes (99202-99215), for both new and established patients. Practices, physicians, and staff must prepare in advance for these changes to ensure a successful transition next year and avoid any disruption in reimbursement.
The American Medical Association’s (AMA) CPT Editorial Panel created a new CPT code effective March 13, 2020 to describe coronavirus testing provided by hospitals, health systems and laboratories in the United States. CPT® Code Description 87635-Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
Starting January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT ®) codes (99202-99215), for both new and established patients. Practices, physicians, and staff must prepare in advance for these changes to ensure a successful transition next year and avoid any disruption in reimbursement.